Trials / Terminated
TerminatedNCT02501005
Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart failure or symptomatic ventricular tachycardia/ventricular fibrillation (VF) when compared to VT ablation after the third appropriate implantable cardioverter-defibrillator (ICD) shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VT ablation | Catheter ablation of ventricular tachycardia |
Timeline
- Start date
- 2015-07-20
- Primary completion
- 2018-07-20
- Completion
- 2018-07-20
- First posted
- 2015-07-17
- Last updated
- 2019-07-08
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02501005. Inclusion in this directory is not an endorsement.